[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Endocrinology](https://durgical.com/en/endocrinology/) › [Obesity and lipids](https://durgical.com/en/endocrinology/areas/obesity-lipids/) › Spotting familial hypercholesterolaemia

# Spotting familial hypercholesterolaemia

- Diagnostic approach

One in about 250 people is born with very high LDL. Untreated, many have heart attacks in their 30s to 50s; found early, they can live a normal life.

Updated Nov 16, 2026

## Key points

- FH ≈ 1 in 250; autosomal dominant; [LDLR](https://durgical.com/en/biochemistry/enzymes/ldl-receptor/) > APOB > [PCSK9](https://durgical.com/en/biochemistry/enzymes/pcsk9/).
- Adult LDL ≥190 mg/dL or child ≥160 mg/dL → think FH.
- Tendon xanthomas are nearly specific; xanthelasma is not.
- Dutch score >8 definite, 6–8 probable.
- Cascade-test first-degree relatives; children from about 2 years.

On this page

- The basics Key points
- What it is
- How to think about it
- What to know
- Step-by-step approach
- FH and its look-alikes
- Common traps
- Elsewhere in DurgiPedia

- Clinical Keys to the differential

- Treatment Next step / Initial management

- Study Test yourself

- Connections Connections

## What it is

[Familial hypercholesterolaemia](https://durgical.com/en/conditions/familial-hypercholesterolemia/) (FH) is an inherited, autosomal dominant disorder of LDL clearance, most often from variants in the LDL receptor gene (LDLR), less often in APOB or gain-of-function PCSK9. Heterozygous FH affects about 1 in 250 people and usually gives LDL of 190 mg/dL or more in adults from birth; homozygous FH is rare and gives LDL usually above 500 mg/dL with heart disease in childhood. The diagnosis rests on LDL, personal and family history, physical signs and, when available, [genetic testing](https://durgical.com/en/biochemistry/topics/genetic-tests-what-each-one-finds/), often scored with the Dutch Lipid Clinic Network criteria.

## How to think about it

FH is a lifetime dose of LDL. The artery wall keeps a running total of LDL × years: someone with FH reaches the heart-attack total decades early. That is why age matters more than the number: lowering LDL in a child or a young adult takes decades off the running total, and why finding one patient means testing the whole family.

## What to know

- Suspect FH with LDL of 190 mg/dL (4.9 mmol/L) or more in an adult, or 160 mg/dL (4.1 mmol/L) or more in a child, after secondary causes are excluded.
- Dutch Lipid Clinic Network criteria in principle: points for family history, premature coronary disease, tendon xanthomas, arcus before 45, LDL level and a causal variant.
- Dutch score: more than 8 definite, 6–8 probable, 3–5 possible, under 3 unlikely; a causal variant or tendon xanthomas alone score highly.
- Tendon xanthomas (Achilles, hand [extensor tendons](https://durgical.com/en/anatomy/extensor-digitorum-tendons/)) are almost specific for FH; xanthelasma is common and non-specific.
- Arcus cornealis before about 45 suggests FH; in older people it is common and meaningless.
- Premature coronary disease in the family: a male first-degree relative before 55 or a female before 60.
- Each child of a heterozygous parent has a 50% chance of inheriting FH.
- Risk calculators underestimate risk in FH; treat with a high-intensity statin, then [ezetimibe](https://durgical.com/en/pharmacology/ezetimibe/) and PCSK9-targeted therapy to reach a 50% fall and the risk target.

## Step-by-step approach

- Find the index case: LDL of 190 mg/dL or more, premature coronary disease, or tendon xanthomas.
- Exclude secondary causes: [hypothyroidism](https://durgical.com/en/conditions/hypothyroidism/), [nephrotic syndrome](https://durgical.com/en/conditions/nephrotic-syndrome/), cholestasis and drugs.
- Take a three-generation family history of LDL, early heart attacks and sudden death.
- Examine Achilles and hand extensor tendons, [eyelids](https://durgical.com/en/anatomy/superior-tarsus/) and corneas.
- Score the Dutch criteria; offer genetic testing when FH is probable or definite and testing is available.
- Treat at once: lifestyle plus a high-intensity statin; add ezetimibe and then PCSK9-targeted therapy as needed.
- Start cascade testing: LDL (and the family variant, if known) in all first-degree relatives, then widen.
- Screen children of affected parents from about age 2; consider a statin from about 8–10 years.

## FH and its look-alikes

| Feature | Heterozygous FH | Polygenic hypercholesterolaemia | Familial combined hyperlipidaemia | Secondary (hypothyroid, nephrotic) |
| --- | --- | --- | --- | --- |
| LDL | Usually 190 mg/dL or more from childhood | Raised, usually less extreme | Raised or normal; changes over time | Raised, appears with the disease |
| Triglycerides | Usually normal | Usually normal | Often raised | Normal or raised |
| Family pattern | Half of first-degree relatives, high LDL | Clusters, no clear pattern | Relatives with different lipid patterns | None |
| Tendon xanthomas | Often | No | No | No (cholestasis gives other xanthomas) |
| Genetic test | LDLR, APOB or PCSK9 variant | Many small-effect variants | Polygenic, no single test | Not needed; treat the cause |

## Keys to the differential

- Every adult with LDL of 190 mg/dL or more deserves a thought about FH, a family history and an offer to test the family.
- Children with FH are often found by testing a parent; universal childhood lipid screening also finds them.
- Women with FH should plan pregnancies; [statins](https://durgical.com/en/pharmacology/classes/statins/) are stopped before conception and resumed after [breastfeeding](https://durgical.com/en/nursing/breastfeeding-support-latch-positions-and-common-problems/).
- Homozygous FH needs specialist care from diagnosis: combined drugs, lipoprotein apheresis and newer agents such as [evinacumab](https://durgical.com/en/pharmacology/evinacumab/) or [lomitapide](https://durgical.com/en/pharmacology/lomitapide/).

## Next step / Initial management

- Repeat LDL with TSH, [glucose](https://durgical.com/en/biochemistry/molecules/glucose/), [creatinine](https://durgical.com/en/biochemistry/molecules/creatinine/), urine protein and [liver](https://durgical.com/en/anatomy/liver/) tests to exclude secondary causes.
- Score the Dutch criteria; offer genetic testing for probable or definite FH where available.
- Start a high-intensity statin, add ezetimibe, then a PCSK9 inhibitor or [inclisiran](https://durgical.com/en/pharmacology/inclisiran/) if LDL stays above target.
- Refer to a lipid clinic or endocrinology every probable or definite FH, every child with suspected FH, and urgently any LDL above 500 mg/dL (possible homozygous FH).

## Common traps

- **A low calculated 10-year risk means a person with FH can wait**: lifelong high LDL makes calculators underestimate risk, so FH is treated regardless of the score.
- **Xanthelasma points to FH**: it is common and non-specific, often with normal lipids; tendon xanthomas are the sign that points to FH.
- **A negative genetic test excludes FH**: a causal variant is not found in a sizeable share of clinical FH, so clinical criteria still guide treatment and cascade testing.
- **Children are too young for lipid testing or statins**: atherosclerosis starts in childhood in FH, and screening from about 2 and statins from about 8–10 years shorten the LDL exposure.
- **Finding FH is about one patient**: it is dominant, so half of first-degree relatives are affected and cascade testing is the most efficient way to find them.

## Test yourself

Think of the answer, then tap the question to see it.

## A 38-year-old man has LDL 260 mg/dL, thickened Achilles tendons and a father who died at 50 of a heart attack. What is the diagnosis and the next step for his family?

Probable or definite FH by the Dutch criteria. Treat him with a high-intensity statin and cascade-test first-degree relatives, including his children.

## A 7-year-old's mother has genetically confirmed FH. When and how should the child be tested?

Now: test LDL and the family variant. With a 50% chance of FH, screening from about age 2 allows statins from about 8–10 years.

## A 70-year-old has arcus cornealis and an LDL of 130 mg/dL. Does the arcus suggest FH?

No: arcus is common with age. It suggests FH only before about 45 years, and his LDL is not in the FH range.

## Why are risk calculators not used to decide treatment in FH?

Because they assume an ordinary lifetime LDL; FH patients have had high LDL since birth, so calculators underestimate their risk.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/endocrinology/spotting-familial-hypercholesterolaemia/)

## Elsewhere in DurgiPedia

- [LDL receptor](https://durgical.com/en/biochemistry/enzymes/ldl-receptor/)
- [PCSK9](https://durgical.com/en/biochemistry/enzymes/pcsk9/)
- [Apolipoprotein B (ApoB-100 and ApoB-48)](https://durgical.com/en/biochemistry/enzymes/apolipoprotein-b/)
- [LDL (low-density lipoprotein)](https://durgical.com/en/biochemistry/topics/ldl/)
- [Cholesterol](https://durgical.com/en/biochemistry/molecules/cholesterol/)
- [Fredrickson classification of hyperlipoproteinaemias](https://durgical.com/en/biochemistry/topics/fredrickson-classification-of-hyperlipoproteinaemias/)

## Connections

## Related 4

- [Reading a lipid profile](https://durgical.com/en/endocrinology/reading-a-lipid-profile/)
- [Cardiovascular risk and who gets a statin](https://durgical.com/en/endocrinology/cardiovascular-risk-and-who-gets-a-statin/)
- [Secondary causes of dyslipidaemia](https://durgical.com/en/endocrinology/secondary-causes-of-dyslipidaemia/)
- [High triglycerides and the pancreatitis threshold](https://durgical.com/en/endocrinology/high-triglycerides-and-the-pancreatitis-threshold/)

## Related conditions 4

- [Familial hypercholesterolemia](https://durgical.com/en/conditions/familial-hypercholesterolemia/)
- [Familial combined hyperlipidaemia](https://durgical.com/en/conditions/familial-combined-hyperlipidaemia/)
- [Familial dysbetalipoproteinemia (type III hyperlipoproteinemia)](https://durgical.com/en/conditions/familial-dysbetalipoproteinemia/)
- [Atherosclerosis and dyslipidaemia](https://durgical.com/en/conditions/atherosclerosis-and-dyslipidaemia/)

## In Pharmacology 8

- [Statins](https://durgical.com/en/pharmacology/classes/statins/)
- [Atorvastatin](https://durgical.com/en/pharmacology/atorvastatin/)
- [Rosuvastatin](https://durgical.com/en/pharmacology/rosuvastatin/)
- [Ezetimibe](https://durgical.com/en/pharmacology/ezetimibe/)
- [PCSK9 inhibitors](https://durgical.com/en/pharmacology/classes/pcsk9-inhibitors/)
- [Inclisiran](https://durgical.com/en/pharmacology/inclisiran/)
- [Evinacumab](https://durgical.com/en/pharmacology/evinacumab/)
- [Lomitapide](https://durgical.com/en/pharmacology/lomitapide/)

[← All of endocrinology](https://durgical.com/en/endocrinology/)

Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.

Sources: [Familial Hypercholesterolemia](https://www.ncbi.nlm.nih.gov/books/NBK556009/) (StatPearls (NCBI Bookshelf), 2022); [Hypercholesterolemia](https://www.ncbi.nlm.nih.gov/books/NBK459188/) (StatPearls (NCBI Bookshelf), 2023); [Xanthoma](https://www.ncbi.nlm.nih.gov/books/NBK562241/) (StatPearls (NCBI Bookshelf), 2026); [Familial Combined Hyperlipidemia](https://www.ncbi.nlm.nih.gov/books/NBK592399/) (StatPearls (NCBI Bookshelf), 2023); [PCSK9 Inhibitors](https://www.ncbi.nlm.nih.gov/books/NBK448100/) (StatPearls (NCBI Bookshelf), 2024).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/endocrinology/spotting-familial-hypercholesterolaemia/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/endocrinology/spotting-familial-hypercholesterolaemia/
